Efficacy and Tolerability of long-acting Octreotide in the Treatment of Thymic Tumors-Reference-Cited by-同舟云学术

Efficacy and Tolerability of long-acting Octreotide in the Treatment of Thymic Tumors

Published:2012-04 Issue:2 Volume:35 Page:105-109
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Longo Flavia,De Filippis Lucilla,Zivi Andrea,Vitolo Domenico,Del Signore Ester,Gori Bruno,Diso Daniele,Anile Marco,Venuta Federico,De Giacomo Tiziano,Coloni Camillo Furio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference32 articles.

1. Thymic malignancies.;Loehrer;Cancer Treat Res,2001

2. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.;Chen;Cancer,2002

3. Histologic classification of thymoma: the World Health Organization and beyond.;Suster;Hematol Oncol Clin North Am,2008

4. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors.;Lardinois;Ann Thorac Surg,2000

5. Follow-up study of thymomas with special reference to their clinical stages.;Masaoka;Cancer,1981

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus;Anti-Cancer Drugs;2023-10-11

2. The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?;Cancers;2022-02-02

3. Thymus;Pathologie;2018-10-30

4. Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience;Lung Cancer;2016-09

5. Systemic Therapies in Thymic Malignancies;Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies;2016